Literature DB >> 1717826

The 40-kilodalton to autoantigen associates with nucleotides 21 to 64 of human mitochondrial RNA processing/7-2 RNA in vitro.

Y Yuan1, E Tan, R Reddy.   

Abstract

A 40-kDa To antigen recognized by sera from some patients with autoimmune diseases is an integral component of both human RNase P and mitochondrial RNA processing (MRP) RNase. Human MRP and RNase P RNAs, synthesized in vitro, readily associate with the To antigen present in the HeLa cell extract. Using this in vitro reconstitution system, the binding site of the To antigen is localized to a 44-nucleotide-long sequence corresponding to nucleotides 21 to 64 of the human MRP RNA. UV cross-linking experiments showed that the To antigen binds directly to MRP RNA and to RNase P (H1) RNA through RNA-protein interactions. Although the MRP RNA and RNAse P (H1) RNA show sequence homology in four conserved blocks (H. A. Gold, J. N. Topper, D. A. Clayton, and J. Craft, Science 245:1377-1380, 1989), the To antigen-binding site in MRP RNA does not show any obvious primary sequence homology with H1 RNA. These data suggest that the To antigen binds to a conserved and presumably a common secondary or tertiary structure in human MRP and RNase P RNAs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717826      PMCID: PMC361579          DOI: 10.1128/mcb.11.10.5266-5274.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Rat nucleolar 7-2 RNA is homologous to mouse mitochondrial RNase mitochondrial RNA-processing RNA.

Authors:  Y Yuan; R Singh; R Reddy
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

2.  The sequence of 5 s ribosomal ribonucleic acid.

Authors:  G G Brownlee; F Sanger; B G Barrell
Journal:  J Mol Biol       Date:  1968-06-28       Impact factor: 5.469

3.  Proteins crosslinked to messenger RNA by irradiating polyribosomes with ultraviolet light.

Authors:  J R Greenberg
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

4.  Are snRNPs involved in splicing?

Authors:  M R Lerner; J A Boyle; S M Mount; S L Wolin; J A Steitz
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

5.  5' flanking sequences of human MRP/7-2 RNA gene are required and sufficient for the transcription by RNA polymerase III.

Authors:  Y Yuan; R Reddy
Journal:  Biochim Biophys Acta       Date:  1991-05-02

6.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Faithful transcription of eukaryotic genes by RNA polymerase III in systems reconstituted with purified DNA templates.

Authors:  P A Weil; J Segall; B Harris; S Y Ng; R G Roeder
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

8.  Immunolocalization of 7-2-ribonucleoprotein in the granular component of the nucleolus.

Authors:  G Reimer; I Raska; U Scheer; E M Tan
Journal:  Exp Cell Res       Date:  1988-05       Impact factor: 3.905

9.  Sequential association of nucleolar 7-2 RNA with two different autoantigens.

Authors:  C Hashimoto; J A Steitz
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

10.  A subset of yeast snRNA's contains functional binding sites for the highly conserved Sm antigen.

Authors:  N Riedel; S Wolin; C Guthrie
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

View more
  24 in total

Review 1.  Eukaryotic ribonuclease P: increased complexity to cope with the nuclear pre-tRNA pathway.

Authors:  S Xiao; F Houser-Scott; D R Engelke
Journal:  J Cell Physiol       Date:  2001-04       Impact factor: 6.384

2.  RNA-protein interactions in the human RNase MRP ribonucleoprotein complex.

Authors:  H Pluk; H van Eenennaam; S A Rutjes; G J Pruijn; W J van Venrooij
Journal:  RNA       Date:  1999-04       Impact factor: 4.942

3.  Protein-RNA interactions in the subunits of human nuclear RNase P.

Authors:  T Jiang; C Guerrier-Takada; S Altman
Journal:  RNA       Date:  2001-07       Impact factor: 4.942

Review 4.  Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes.

Authors:  Shaohua Xiao; Felicia Scott; Carol A Fierke; David R Engelke
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

5.  Functional equivalence of hairpins in the RNA subunits of RNase MRP and RNase P in Saccharomyces cerevisiae.

Authors:  L Lindahl; S Fretz; N Epps; J M Zengel
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

6.  Functional characterization of the Drosophila MRP (mitochondrial RNA processing) RNA gene.

Authors:  Mary D Schneider; Anupinder K Bains; T K Rajendra; Zbigniew Dominski; A Gregory Matera; Andrew J Simmonds
Journal:  RNA       Date:  2010-09-20       Impact factor: 4.942

7.  Heterodimerization regulates RNase MRP/RNase P association, localization, and expression of Rpp20 and Rpp25.

Authors:  Tim J M Welting; Florence M A Peters; Sanne M M Hensen; Nienke L van Doorn; Bastiaan J Kikkert; Jos M H Raats; Walther J van Venrooij; Ger J M Pruijn
Journal:  RNA       Date:  2006-11-21       Impact factor: 4.942

8.  Characterization of two scleroderma autoimmune antigens that copurify with human ribonuclease P.

Authors:  P S Eder; R Kekuda; V Stolc; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

9.  A functional dominant mutation in Schizosaccharomyces pombe RNase MRP RNA affects nuclear RNA processing and requires the mitochondrial-associated nuclear mutation ptp1-1 for viability.

Authors:  J L Paluh; D A Clayton
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

10.  Association of RNase mitochondrial RNA processing enzyme with ribonuclease P in higher ordered structures in the nucleolus: a possible coordinate role in ribosome biogenesis.

Authors:  B Lee; A G Matera; D C Ward; J Craft
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.